This HTML5 document contains 141 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1093/ANNONC/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34785845
rdf:type
wikibase:Item
schema:description
บทความทางวิทยาศาสตร์ 2008 թվականի հունիսին հրատարակված գիտական հոդված наукова стаття, опублікована в червні 2008 2008年论文 مقالهٔ علمی artykuł naukowy 2008年論文 scienca artikolo научна статия سائنسی مضمون articol științific artikull shkencor 2008年論文 2008年论文 مقالة علمية 2008年論文 мақолаи илмӣ artigo científico 2008년 논문 2008年论文 artigo científico (publicado na 2008) 2008 թուականի Յունիսին հրատարակուած գիտական յօդուած vetenskaplig artikel tudományos cikk научни чланак bài báo khoa học wetenschappelijk artikel vitskapeleg artikkel article scientifique (publié 2008) 2008年論文 videnskabelig artikel (udgivet 2008) bilimsel makale научни чланак 2008年の論文 mokslinis straipsnis naučni članak vědecký článek სამეცნიერო სტატია 2008年论文 2008年論文 scientific article επιστημονικό άρθρο articolo scientifico teaduslik artikkel vitenskapelig artikkel tieteellinen artikkeli artigo científico (publicado na 2008) 2008年论文 ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículu científicu espublizáu en 2008 מאמר מדעי article scientific vedecký článok мақолаи илмӣ научная статья wissenschaftlicher Artikel 2008 nî lūn-bûn artículo científico publicado en 2008 artikulong pang-agham 2008年论文 article científic
p:P577
wds:Q34785845-8074097F-1AE9-4649-9F6E-12F0DB768B81
wdt:P577
2008-06-09T00:00:00Z
p:P2860
wds:Q34785845-9225B300-9BA9-451E-8005-4942C5843329 wds:Q34785845-9DF852C8-A572-4B07-9DA4-B3D0676CFDE2 wds:Q34785845-C2B0A722-A463-4271-A5A5-F26D442E5733 wds:Q34785845-C3AA994A-42D8-4669-B7B0-30E94EEF015D wds:Q34785845-DF87BBC9-4960-4EDB-AB84-DA3A827903A5 wds:Q34785845-A682F00B-9169-43F2-A8D7-C0A965028972 wds:Q34785845-AC5FD6A0-48C9-4B19-8D07-231FFC482CF0 wds:Q34785845-413AE6EF-2519-45BC-9CAD-5A95CF01F10A wds:Q34785845-432CEDAD-A37D-43D6-B14E-A34C782412EE wds:Q34785845-4C9231A2-3A7B-4D99-8E96-57D0625E2273 wds:Q34785845-63AE1A25-EC1C-4568-BEB2-2584B40F79BF wds:Q34785845-52F003B9-A0A9-403F-BCC3-21FD9C013C16 wds:Q34785845-5742660D-E191-402A-BF1A-4C135A0EDE91 wds:Q34785845-583B5AEA-0FDF-4148-AAFF-4DA1D278A913
wdt:P2860
wd:Q46469676 wd:Q36900213 wd:Q24531307 wd:Q46832068 wd:Q34391627 wd:Q40257551 wd:Q46944902 wd:Q40235755 wd:Q35702447 wd:Q24678072 wd:Q35089350 wd:Q44933829 wd:Q41366414 wd:Q47647750
p:P2093
wds:Q34785845-6612BFF8-FE74-4D87-9D04-58050FC05E1A wds:Q34785845-66960268-CBFC-40A8-B773-4A46EE914069 wds:Q34785845-0C6CCEF4-A576-4821-A99C-1BEE0040C4EA wds:Q34785845-17859CF9-6D63-46CA-BE6F-A8D89EB45ADC wds:Q34785845-862D493B-1141-4B1D-838E-3DF8241F58E3 wds:Q34785845-8844A261-ABA6-46B8-9C74-D9CE358C2C41 wds:Q34785845-B18BFDDC-C2ED-4DE8-9356-30273FC2E286 wds:Q34785845-2FCBE603-6BF8-4F01-AA6F-F03714852BDB wds:Q34785845-4C760D79-DE68-4C5A-8C01-AF6CF623FEBF
wdt:P2093
S Assouline K Rosadiuk C Rousseau D Melnychuk L Robitaille W H Miller M Levine S J Padayatty L J Hoffer
rdfs:label
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy Phase I clinical trial of i.v. ascorbic acid in advanced malignancy Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
skos:prefLabel
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy Phase I clinical trial of i.v. ascorbic acid in advanced malignancy Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
schema:name
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy Phase I clinical trial of i.v. ascorbic acid in advanced malignancy Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
p:P1476
wds:Q34785845-1CE589B8-CFDB-49D4-8A7A-2BF8B015993D
wdt:P1476
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
p:P304
wds:Q34785845-3DEF4602-AD63-4E01-B720-CE6B98C71ADC
wdt:P304
1969-1974
p:P31
wds:Q34785845-B502795B-D6C5-4BF7-B9DE-D15B0E9BDCCA
wdt:P31
wd:Q13442814
p:P921
wds:Q34785845-7A09A1E2-D099-44B9-B1FB-F53CAB4A2524
wdt:P921
wd:Q5452194
p:P698
wds:Q34785845-6DD7D720-AC66-44F7-AD72-2A61749C3502
wdtn:P698
n11:18544557
wdt:P698
18544557
p:P1433
wds:Q34785845-556F6758-83F9-4C20-BC17-E82672A98247
wdt:P1433
wd:Q326122
p:P433
wds:Q34785845-73B7C943-DB51-4023-ABBC-15D9E83D6FC8
p:P478
wds:Q34785845-08C27DCC-7107-44AA-8026-02DE0BDDEE2A
wdt:P433
11
wdt:P478
19
p:P356
wds:Q34785845-5F6FBC7E-927B-4E55-BAB2-7F3605A2A194
wdtn:P356
n10:MDN377
wdt:P356
10.1093/ANNONC/MDN377
p:P5875
wds:Q34785845-227D393A-C012-435B-AFEF-939CF10AE701
wdt:P5875
5311840